INTRODUCTION
pH-weighted imaging has previously shown promise in the depiction of acute stroke (1) since it is able to distinguish tissues with or without metabolic acidosis, before irreversible damage occurs. Amide proton transfer (APT) imaging, a variant of chemical exchange saturation transfer (CEST) imaging, has been experimentally (2) and clinically (3) evaluated in stroke, to depict pH-weighted differences using endogenous contrast of intermediately exchanged amide protons at 3.5 ppm. This new imaging biomarker may have the potential to be incorporated into stroke imaging protocols, since depicting ischemic penumbra remains a challenge using computed tomography or diffusion-or perfusion-weighted magnetic resonance imaging (MRI) (4) (5) (6) . However, to date, clinical studies have been sparse for APT imaging in stroke (3) .
Hurdles for the clinical application of APT imaging include the practical concern of applying a new imaging biomarker in patients with acute stroke, and the technical limitations of achieving sufficient pH-weighted differences between ischemic and unaffected tissue. Tietze et al. (3) addressed the limitations of APT imaging with a 3-dimensional (3D) gradient-echo sequence that counters the effects of B 0 field inhomogeneity and direct water saturation capable of obscuring lesions in the vicinity of the cerebrospinal fluid space. The recent development of the 3D turbo spinecho (TSE) sequence with 2-channel parallel radiofrequency (RF) transmission (7) may provide more robust motion and artifact correction, compared to the gradient-echo protocol, enabling a sufficiently long saturation time. Using this spinecho sequence, optimization of off-resonance RF power was tested at 1, 2, and 3 μT with a 500 ms saturation time. However, this saturation time is short and possibly not optimal, as the cumulative pH-weighted effect on the water is maximized when the labeling process is given a sufficiently long saturation time (8) .
Since no current literature is available for optimizing the saturation time with TSE APT imaging at 3T for stroke model, we evaluated clinically feasible saturation times, in order to maximize the pH-weighted difference between the normal appearing brain (NAB) and ischemic regions. Unlike a previous phantom study (9) , we used an in vivo middle cerebral artery occlusion (MCAO) rat model, followed by histopathological staining, to translate the 3T TSE APT sequence into the clinic. The purpose of our study was to optimize the saturation time, thus maximizing the pHweighted difference between the normal appearing brain and ischemic regions on 3T APT imaging, using an in vivo rat model.
MATERIALS AND METHODS

Animal Model
Adult male Wistar rats weighing between 290 to 350 g, were anesthetized (intra-peritoneal chloral hydrate) and immobilized. All animal procedures were approved by our Institutional Animal Care and Use Committee. Permanent MCAO was applied by inserting a 4-0 silk suture coated with a commercialized silicon rubber-coated 5-0 nylon monofilament (tip diameter: 0.35-0.37 mm) into the lumen of the internal carotid artery, to block the origin of the middle cerebral artery. Immediately after completion of the MRI procedure, the rats were sacrificed, and their brains were removed for histological examination. The infarct core was visualized by applying 2, 3, 5-triphenyltetrazolium hydrochloride (TTC) staining. The time interval from MCAO occlusion to MR imaging was 30 minutes.
APT Imaging Acquisition Theoretical background for APT experiment
For APT imaging, an off-resonance RF pulse was applied with a sinc-Gauss pulse at a B 1,rms amplitude of 1.2 μT. Theoretical background for applying a B 1,rms amplitude of 1.2 μT was adopted from Sun et al. (9) using interleaved continuous wave-or pulsed-CEST imaging with singleshot spin-echo (SE) echo planar readout investigated APT asymmetry in stroke on 3T. The study showed that the optimal RF power is approximately 1 μT on 3T, which sufficiently labels the exchangeable protons with minimal spillover effects. On the other hand, Zhao et al. (10) showed that a 2 μT amplitude had better APT difference compared to 1 or 3 μT, but the study was based on a duration of 500 ms. We adopted an amplitude of 1.2 μT, in order to maximize the pH-weighted effect using 3T TSE imaging.
In our study, APT imaging was tested using different saturation times (3, 4, and 5 seconds) at 1.2 μT.
APT acquisition in rat model and a patient APT acquisition was performed in a 3T clinical scanner (Ingenia 3.0 CX, Philips Healthcare, Best, the Netherlands) using a 32-channel head coil and 2-channel parallel RF transmission, Using a 3-dimensional TSE imaging protocol. The two alternating transmission RF channels enabled a long quasi-continuous saturation RF pulse train beyond the 100% duty cycle (7). The off-resonance frequency used for the saturation RF pulse was irradiated at 7 frequency offsets with 9 acquisitions (-2.7, +2.7, -3.5, +3.5 [3 acquisitions at different echo times (TE)], -4.3, +4.3, -1560 ppm). A B0 map for off-resonance corrections was estimated using the data acquired at 3 different TEs (TE = ±0.4 ms), with an iterative filtering and mapping procedure with spatial smoothing (11) . This procedure was adapted for the 3-point Dixon method (12) , and was available from the current scanner software.
For the rat model, the other imaging parameters were as follows: repetition time (TR), 4500-5500 ms; echo time (TE), 5. 
Data Analysis
Maps of the magnetization transfer (MT) asymmetry MTRasym = (S[-3.5 ppm]-S[+3.5 ppm])/S0 were calculated Free-hand regions-of-interests (ROIs) were drawn by a neuroradiologist (J.E.P.) at the high signal lesion on DWI on the MR console, using the software incorporated into the MR imaging unit. The same ROI trace was then transferred to the contralateral NAB, and APTw signal was calculated. The APTw signal difference between the ischemic regions and the NAB was calculated and compared among different saturation times. Quantitative analysis was obtained for 5 slices from each rat. The Kruskall-Wallis test was performed to compared the 3,4, and 5 s conditions.
RESULTS
The MCAO model was successfully applied in all 3 Wistar rats, with acceptable quality of APT images in all cases. Figure 1 shows that the APT imaging depicted the ischemic region, and that this changed noticeably between the 3-, 4-, and 5-second conditions. Table 1 summarizes the quantitative results for the 3-, 4-, and 5-second conditions. The APTw signal difference between the ischemic regions and NAB was maximized in the 4-second protocol. The median APT difference for the 3-, 4-, and 5-second protocols was -1.03%, -1.22%, and -0.82%, respectively. Notably, the APT difference was reduced in the 5-second protocol compared to the 3-second protocol. On Kruskall-Wallis test, the APTw signal difference on the 4-second protocol was significantly larger than the 3-or 5-second protocols (-0.95%, p = 0.029) DWI and TTC staining showed decreased APTw signal, corresponding to the diffusion restriction region and nonstain regions on TTC staining (Fig. 2) .
The protocol was applied to a patient 4 days after a middle cerebral artery infarction, and it successfully depicted APT contrast between the ischemic region and NAB (Fig. 3 ).
DISCUSSION
Our study utilized APT imaging at 3-T (3T), and we present the difference between ischemic region and normal appearing region in both an in vivo rat model and a human case. We adopted the saturation power from a study by Sun et al. (9) on 3T tested different saturation times, ranging from 3 to 5 s, and showed that the maximal APT difference was achieved with a saturation time of 4 s at an amplitude of 1.2 μT. The results of our study support the clinical use of 3T APT imaging with fast multi-slice imaging and an automatic image processing algorithm. The rat brain is considerably smaller than the human brain, but negative contrast in ischemic regions was successfully depicted. In addition, the same saturation time was applied to a patient with acute stroke, and we successfully illustrated the APT contrast within a scan time of 2 minutes and 30 seconds.
Interestingly, a longer saturation time does not correspond to better APT contrast. Saturation times of 3 and 4 s gave better contrast between ischemic regions and the NAB, as compared to 5 s. This may come from a coexisting solid macromolecular MT effect (9, 13) that is more pronounced at a higher RF power, or possible intra-and inter-molecular nuclear Overhauser effects (10) . Similar results were obtained by Sun et al. (9) , who showed that the optimal saturation power is achieved at around 1 μT, and APT contrast decreased at higher power fields. Since clinical scanners have specific absorption rate limitations, low power levels will be more beneficial than higher power levels. On the other hand, a longer saturation time is beneficial for the cumulative effect on water, which gets maximized when the labeling process is given with a sufficiently long saturation time (8) .
The use of APT imaging has been suggested to help stroke depiction by subdividing the perfusion-diffusion mismatched region into regions with and without tissue acidosis (1, 2) . Diffusion restricted regions often represent an ischemic core, but they can sometimes recover (14) , and perfusion-weighted imaging also includes regions with benign oligemia. A pH-sensitive MR imaging may depict metabolic heterogeneity within homogenously-looking diffusion restriction areas. Previous studies found that average pH-weighted imaging deficits were always equal to or larger than the diffusion restricted regions, but smaller than the perfusion deficits (15, 16) . The pH-weighted imaging depicts regions with impaired metabolism that are still reversible (15) . It has the potential to differentiate areas with "infarction" from those of "salvageable tissue" using mismatch areas between diffusion-weighted imaging and pH-weighted imaging. Thus, APT imaging is expected to more precisely delineate tissue-at-risk regions, in which both a pH (reduced APT regions) and perfusion decrease has occurred, and subsequently guide patients on further The main limitation of our study is that it was conducted on a small number of subjects. Moreover, APT imaging can be affected by other signal contributors of broad macromolecular magnetization and spin-lattice relaxation (13, 17, 18) ; thus, the signal source of APT imaging in stroke needs to be further investigated. However, our study has successfully demonstrated APT contrast in an in vivo rat model using a 3 T protocol and 32-channel head coil that can translate immediately into the clinic.
In conclusion, the maximal pH-weighted difference was achieved with a 4 s saturation time when using a 1.2 μT power level with 3T TSE APT imaging. The protocol was successfully applied to a stroke patient, and will be helpful to depict pH-weighted difference in stroke patients in the clinic.
